Inspire Medical Systems, Inc. to Report Second Quarter 2025 Financial Results on August 4, 2025
Inspire Medical Systems (NYSE: INSP) has scheduled its second quarter 2025 financial results release for August 4, 2025 after market close. The company will host a conference call at 5:00 p.m. Eastern Time to discuss financial performance and business updates.
Investors can access the earnings call through two methods: a webcast via the company's Investor Relations website for those planning to listen only, or a separate registration link for those intending to ask questions. The company recommends registering at least 10 minutes before the call. A replay will be available on the Investor Relations website approximately two hours after the event and will be archived for two weeks.
Inspire Medical Systems (NYSE: INSP) ha programmato la pubblicazione dei risultati finanziari del secondo trimestre 2025 per il 4 agosto 2025 dopo la chiusura del mercato. L'azienda terrà una conference call alle 17:00 ora della costa orientale per discutere le prestazioni finanziarie e gli aggiornamenti aziendali.
Gli investitori potranno partecipare alla chiamata dei risultati attraverso due modalità: una diretta web tramite il sito Investor Relations della società, riservata a chi desidera solo ascoltare, oppure un link di registrazione separato per chi intende porre domande. La società consiglia di registrarsi almeno 10 minuti prima della chiamata. Una registrazione sarà disponibile sul sito Investor Relations circa due ore dopo l'evento e sarà archiviata per due settimane.
Inspire Medical Systems (NYSE: INSP) ha programado la publicación de sus resultados financieros del segundo trimestre de 2025 para el 4 de agosto de 2025 después del cierre del mercado. La empresa realizará una conferencia telefónica a las 5:00 p.m., hora del Este para discutir el desempeño financiero y las novedades comerciales.
Los inversores pueden acceder a la llamada de resultados de dos maneras: a través de una transmisión por internet en el sitio web de Relaciones con Inversionistas de la compañía para quienes solo deseen escuchar, o mediante un enlace de registro separado para quienes quieran hacer preguntas. La empresa recomienda registrarse al menos 10 minutos antes de la llamada. Una grabación estará disponible en el sitio web de Relaciones con Inversionistas aproximadamente dos horas después del evento y se archivará durante dos semanas.
Inspire Medical Systems (NYSE: INSP)는 2025년 2분기 재무 실적 발표를 2025년 8월 4일 장 마감 후에 예정하고 있습니다. 회사는 재무 성과와 사업 업데이트를 논의하기 위해 동부 표준시 오후 5시에 컨퍼런스 콜을 진행할 예정입니다.
투자자들은 두 가지 방법으로 실적 발표 콜에 참여할 수 있습니다: 듣기만 원하는 경우 회사의 투자자 관계 웹사이트를 통한 웹캐스트, 질문을 하려는 경우 별도의 등록 링크를 이용할 수 있습니다. 회사는 콜 시작 최소 10분 전까지 등록할 것을 권장합니다. 행사가 끝난 약 두 시간 후 투자자 관계 웹사이트에서 재생이 가능하며, 2주간 보관됩니다.
Inspire Medical Systems (NYSE : INSP) a programmé la publication de ses résultats financiers du deuxième trimestre 2025 pour le 4 août 2025 après la clôture du marché. La société organisera une conférence téléphonique à 17h00, heure de l'Est pour discuter des performances financières et des mises à jour commerciales.
Les investisseurs peuvent accéder à l’appel sur les résultats de deux manières : via un webcast sur le site des Relations Investisseurs de la société pour ceux qui souhaitent uniquement écouter, ou via un lien d’inscription séparé pour ceux qui souhaitent poser des questions. La société recommande de s’inscrire au moins 10 minutes avant l’appel. Une rediffusion sera disponible sur le site des Relations Investisseurs environ deux heures après l’événement et sera archivée pendant deux semaines.
Inspire Medical Systems (NYSE: INSP) hat die Veröffentlichung der Finanzergebnisse für das zweite Quartal 2025 für den 4. August 2025 nach Börsenschluss geplant. Das Unternehmen wird um 17:00 Uhr Eastern Time eine Telefonkonferenz abhalten, um die finanzielle Entwicklung und Geschäftsaktualisierungen zu besprechen.
Investoren können auf die Ergebnispräsentation auf zwei Wegen zugreifen: per Webcast über die Investor-Relations-Website des Unternehmens, wenn sie nur zuhören möchten, oder über einen separaten Registrierungslink, wenn sie Fragen stellen wollen. Das Unternehmen empfiehlt, sich mindestens 10 Minuten vor der Konferenz zu registrieren. Eine Aufzeichnung wird etwa zwei Stunden nach der Veranstaltung auf der Investor-Relations-Website verfügbar sein und für zwei Wochen archiviert.
- None.
- None.
MINNEAPOLIS, July 07, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2025 after the close of trading on Monday, August 4. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q2 2025 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.
If you plan to ask a question, please use the following link: Inspire's Q2 2025 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.
Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
